Warning Letter Review By FDA Chief Counsel’s Office Will Take Five Days
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Chief Counsel will have five working days to review warning letters that previously were sent directly to manufacturers from district offices
You may also be interested in...
Paper Tigers Or Paper Bullets? FDA Cutting Down On Repeat GMP Warnings
FDA enforcement policies being carried out by the Office of the Chief Counsel could eliminate the practice of issuing multiple manufacturing compliance warning letters
Unsupported Supplement Claims Should Be Brought To FDA By Industry – Troy
Dietary supplement trade associations and their members should alert FDA to companies they believe are making false or misleading labeling claims, agency Chief Counsel Daniel Troy said
FDA Warning Letter Review Suggests Aggressive Action Needed, Troy Says
The FDA Office of Chief Counsel's review of warning and untitled letters suggests the agency should be taking more aggressive enforcement actions, Chief Counsel Daniel Troy suggested Feb. 21